Book Closure

JAGSONPAL PHARMACEUTICALS LTD.

NSE : JAGSNPHARMBSE : 507789ISIN CODE : INE048B01027Industry : Pharmaceuticals & DrugsHouse : Jagsonpal
BSE323.0535.25 (+12.25 %)
PREV CLOSE ( ) 287.80
OPEN PRICE ( ) 292.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19080
TODAY'S LOW / HIGH ( )286.95 335.50
52 WK LOW / HIGH ( )270.05 513.9
NSE321.4534.15 (+11.89 %)
PREV CLOSE( ) 287.30
OPEN PRICE ( ) 291.80
BID PRICE (QTY) 321.45 (201)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 154255
TODAY'S LOW / HIGH( ) 289.10 331.50
52 WK LOW / HIGH ( )273.6 514.85

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.